XML 55 R38.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Stock options granted have a maximum term of ten years from the grant date, are exercisable upon vesting and typically vest over a period of four years. Stock option activity for the year ended December 31, 2025 was as follows:
Number of Options OutstandingWeighted-Average Exercise Price
(Per share)		Weighted-Average Remaining Life
(In years)		Aggregate Intrinsic Value
(In thousands)
Outstanding at January 1, 20251,425,656 $12.17 5.2$31,223 
Exercised(452,638)9.59 
Forfeited or cancelled(12,539)13.92 
Outstanding at December 31, 2025960,479 $13.36 4.3$33,385 
Vested and exercisable at December 31, 2025960,479 $13.36 4.3$33,385 
Schedule of RSU Activity
RSUs granted typically vest over four years. RSU activity for the year ended December 31, 2025 was as follows:
SharesWeighted-Average Grant Date Fair Value
 (Per share)
Unvested balance at January 1, 20255,215,300 $36.40 
Granted2,714,355 36.87 
Vested(2,173,661)37.15 
Forfeited or cancelled(1,299,849)35.91 
Unvested balance at December 31, 20254,456,145 $36.46 
Vested and expected to vest at December 31, 20253,664,193 $36.34 
Schedule of PRSU Activity
The Company has issued PRSUs which vest based on the achievement of each award’s established performance targets. PRSU activity for the year ended December 31, 2025 was as follows:
SharesWeighted-Average Grant Date Fair Value
(Per share)
Unvested balance at January 1, 2025183,919 $36.09 
Granted436,972 30.75 
Vested(58,692)35.51 
Forfeited or cancelled(158,616)30.75 
Adjusted by performance factor(88,865)36.48 
Unvested balance at December 31, 2025314,718 $31.37 
Vested and expected to vest at December 31, 2025312,900 $31.37 
Summary of Share-Based Payment Arrangement and Price Targets A cumulative percentage of the MRSU target is earned based on the achievement of stock price goals, measured based on the average of the Company’s closing stock price over a consecutive 60 trading day period during the performance period as set forth in the table below:
TrancheCompany Stock Price TargetTotal Payout
1$65.00
25% of Target MRSUs
2$100.00
50% of Target MRSUs
3$135.00
100% of Target MRSUs
4$170.00
150% of Target MRSUs
Schedule of Weighted-Average Assumptions
The following assumptions were used in the Monte Carlo simulation model to estimate the grant date fair value and the derived service period of the MRSUs:
Expected volatility71.3%
Expected term (in years)
5.0
Risk-free interest rate4.1%
Dividend yield—%
Stock price at grant date (per share)
$39.43
Weighted-average fair value of awards (per share)
$27.61
Summary of Stock-Based Compensation Expense
Stock-based compensation is included in the consolidated statements of operations as follows:
Year Ended December 31,
202520242023
Cost of revenue(1)
$5,435 $5,889 $5,685 
Research and development(1)
34,939 38,285 42,040 
Sales and marketing(1)
11,646 10,093 13,177 
General and administrative (2)
28,295 36,278 23,508 
Restructuring and other charges— — 3,937 
Total$80,315 $90,545 $88,347 
___________________
(1) Amounts for the year ended December 31, 2023 have been recast to conform with current period presentation. Refer to Note 2. Summary of Significant Accounting Policies, Prior Period Reclassification, for further details.
(2) Amount includes $31,279 of recognized stock-based compensation related to the Company’s former CEO’s MRSUs that was estimated to be forfeited and therefore reversed for the year ended December 31, 2023.